CHERYL WALKER to Uterine Neoplasms
This is a "connection" page, showing publications CHERYL WALKER has written about Uterine Neoplasms.
Connection Strength
2.847
-
Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol Cancer Res. 2012 Apr; 10(4):546-57.
Score: 0.340
-
Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer Res. 2009 Aug 01; 69(15):6171-8.
Score: 0.282
-
Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats. Clin Cancer Res. 2007 May 15; 13(10):3087-99.
Score: 0.243
-
Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats. Reprod Sci. 2007 Feb; 14(2):121-36.
Score: 0.238
-
Uterine fibroids: the elephant in the room. Science. 2005 Jun 10; 308(5728):1589-92.
Score: 0.212
-
Altered extracellular matrix-related pathways accelerate the transition from normal to prefibroid myometrium in Black women. Am J Obstet Gynecol. 2024 Sep; 231(3):324.e1-324.e12.
Score: 0.198
-
Treatment strategies for uterine leiomyoma: the role of hormonal modulation. Semin Reprod Med. 2004 May; 22(2):105-11.
Score: 0.197
-
Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. Genes Chromosomes Cancer. 2003 Dec; 38(4):349-56.
Score: 0.191
-
Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. Cancer Res. 2003 Mar 15; 63(6):1221-7.
Score: 0.182
-
Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells. Mol Cell Endocrinol. 2002 Oct 31; 196(1-2):11-20.
Score: 0.177
-
Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma. Recent Prog Horm Res. 2002; 57:277-94.
Score: 0.167
-
Endocrine-disrupting chemicals and uterine fibroids. Fertil Steril. 2016 09 15; 106(4):967-77.
Score: 0.115
-
Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model. Gynecol Obstet Invest. 2009; 68(1):19-32.
Score: 0.069
-
Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation. Hum Reprod. 2008 Feb; 23(2):440-6.
Score: 0.063
-
Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling. J Soc Gynecol Investig. 2003 Jan; 10(1):11-20.
Score: 0.045
-
Treatment of uterine leiomyosarcoma in a xenograft nude mouse model using high-intensity focused ultrasound: a potential treatment modality for recurrent pelvic disease. Gynecol Oncol. 2002 Sep; 86(3):344-50.
Score: 0.044
-
Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function. Cancer Res. 2002 Jul 01; 62(13):3766-72.
Score: 0.043
-
Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis. Stem Cells. 2017 03; 35(3):666-678.
Score: 0.029
-
Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration. Am J Physiol Lung Cell Mol Physiol. 2002 Apr; 282(4):L854-62.
Score: 0.011